BSE · 524808
Phyto Chem (India) Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹17 Cr with net profit ₹-1 Cr — a -5.99% net margin, versus -19.44% the period before.
Shareholding
As of 2026-06-30
- Promoter40.4%
- Public59.41%
- DII0.19%
7,314 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.89× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — GSM · GSM 0. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Pesticides / Agrochemicals - Indian · ranked #27 of 29 by market cap · medians across 26 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| UPL Limited | ₹51,339 Cr | 28.76 | 1.48 | 5.54% | 3.71% |
| PI Industries Ltd. | ₹41,472 Cr | 207.08 | 3.7 | 11.76% | 0.2% |
| Sumitomo Chemical India Ltd. | ₹25,027 Cr | 43.79 | 7.38 | 16.02% | 17.86% |
| Sharda Cropchem Ltd. | ₹7,706 Cr | 24.18 | 2.46 | 21.71% | 12.93% |
| Dhanuka Agritech Ltd. | ₹4,582 Cr | 46.86 | 2.73 | 21.17% | 14.59% |
| NACL Industries Limited | ₹4,467 Cr | — | 6.54 | 2.49% | 0.29% |
| Rallis India Ltd. | ₹3,781 Cr | 28.19 | 2.03 | 9.99% | 6.31% |
| Bhagiradha Chemicals & Industries Ltd. | ₹3,450 Cr | 858.39 | 4.94 | 2.6% | 3.39% |
| Bharat Rasayan Ltd. | ₹2,139 Cr | 56.08 | 1.68 | 11.43% | 11.73% |
| Insecticides India Ltd. | ₹1,852 Cr | 158.35 | 1.52 | 0.11% | 6.51% |
| Phyto Chem (India) Ltd.(this company) | ₹9 Cr | — | 1.96 | -39.45% | -19.87% |
AI analysis
AI-generated · google/gemini-2.5-flashPhyto Chem (India) Ltd. is listed with a market capitalization of Rs 10 Cr. The company reported a net profit of -0.9915 Cr in March 2025 on revenue of 16.5511 Cr. The book value per share is 10.63, with an EPS of -2.31. The promoter holding stands at 40.4007% as of June 2026.
Positives
- +Promoter pledge is 0%, indicating no shares have been pledged by promoters.
Negatives
- −The company's revenue declined to 16.5511 Cr in March 2025 from 45.2927 Cr in March 2021, representing a decrease of 63.45%.
- −Net profit has been negative for the past two annual periods, with -3.3306 Cr in March 2024 and -0.9915 Cr in March 2025.
- −The profit margin is negative at -19.87%.
- −Return on Equity (ROE) is negative at -39.45% and Return on Capital Employed (ROCE) is negative at -1.4454%.
- −The debt-to-equity ratio is high at 2.47.
- −The company is under the Graded Surveillance Measure (GSM) framework.
- −No EPS figures are available for quarterly results since Dec 2024.
Financial performance
The company's revenue declined to 16.5511 Cr in March 2025 from 26.9185 Cr in March 2023. Net profit has been negative for the past two annual periods, reporting -3.3306 Cr in March 2024 and -0.9915 Cr in March 2025. Quarterly revenue has fluctuated, from a high of 3.65 Cr in Dec 2024 to a low of 0.23 Cr in Mar 2026.
Profitability & returns
Phyto Chem (India) Ltd. recorded a negative profit margin of -19.87%. The Return on Equity (ROE) is -39.45% and Return on Capital Employed (ROCE) is -1.4454%. Earnings per share (EPS) was -2.31 in March 2025, after being 0.52 in March 2023.
Balance sheet
The company has a debt-to-equity ratio of 2.47. The book value per share is 10.63. There is no dividend yield reported for the company.
Ownership & pledges
Promoter shareholding is 40.4007% as of June 2026. Public ownership is 59.4133% and institutional holding is 0.186%. There are no promoter pledges reported. The total number of shareholders is 7314 as of June 2026.
Regulatory & surveillance
The company is under the Graded Surveillance Measure (GSM) framework, specifically identified as 'GSM 0'.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.